APELLIS PHARMACEUTICALS

SYFOVRE

Manufacturer:

APELLIS PHARMACEUTICALS

Syfovre HCPCS:

C9151

HCPCS Code Descriptor:

Injection, pegcetacoplan, 1 mg

Category:

C Code

Syfovre NDCs:

Primary Type:

Opthalmic

Generic/Specialty Status:

Single-Source

Route of Administration:

Intraocular

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Syfovre:

SYFOVRE is a Opthalmic drug manufactured by APELLIS PHARMACEUTICALS and administered via the Intraocular route of administration. The C Code: C9151 is aligned to the drug SYFOVRE.

SYFOVRE belongs to the class of drugs known as monoclonal antibodies. This medication works by targeting the C3 and C3b proteins. SYFOVRE can be used to help slow the growth of geographic atrophy lesions. This medication is produced by Apellis pharmaceuticals and is aligned to the HCPCS code C9151. Patient assistance programs for this medication can be found through Apellis Assist.

ACCESS PRICING AND MORE BY REGISTERING

C9151 Added Date:

July 1, 2023

C9151 Effective Date:

July 1, 2023

C9151 Termination Date:

September 30, 2023

We have not yet identified a manufacturer source of Syfovre billing and coding information.
Syfovre patient assistance information can be found through Apellis at the URL: https://apellis.com/our-products/
SYFOVRE prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for SYFOVRE. Please check back in a few weeks.